Coherus Delivers With Pegfilgrastim Autoinjector Launch

New Version Of Udenyca US Neulasta Biosimilar Comes Ahead Of On-Body Device

 
• By Dave Wallace

Amid increasing competition on biosimilar pegfilgrastim in the US, Coherus is looking to bolster its position with the launch of an Udenyca autoinjector presentation, while it awaits approval for a rival to Amgen’s Neulasta Onpro on-body injector device later this year.

A red hot air balloon standing out in a sea of white hot air balloons
Coherus is looking to stand out among a host of pegfilgrastim biosimilars • Source: Shutterstock

More from Biosimilars

More from Products